Form 4: HCW Biologics CEO Buys Shares
Insider Transaction (Form 4)
Hing C Wong, Chief Executive Officer, a Director and 10% owner of HCW Biologics Inc., purchased 23,210 shares of common stock on July 29, 2026 for $2.58 per share.
Summary
- Open-market purchase: acquired 23,210 Common Stock at $2.58 ($59,998) on July 29, 2026; holds 125,845 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $59,998, committing personal capital to the stock.
Insider Transactions
Hing C Wong — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-29 | Open-market purchase | Common Stock | 23,210 | $3 | $60.0K | 125,845 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-29 | Open-market purchase (23,210 shares) |
Keywords
insider transaction, Form 4, HCWB, HCW Biologics Inc., bullish, Hing C Wong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.